Related Experiment Videos
Dexamethasone-induced hepatomegaly in three children
A Verrips1, J J Rotteveel, R Lippens
1Department of Paediatric Neurology, University Hospital Nijmegen, The Netherlands.
Pediatric Neurology
|January 8, 1999
Summary
High-dose dexamethasone treatment caused reversible liver enlargement and dysfunction in children. Discontinuing dexamethasone therapy restored normal liver size and function, indicating a direct causal link.
Area of Science:
- Pediatric Endocrinology
- Hepatology
- Pharmacology
Background:
- Dexamethasone is a potent corticosteroid used in various pediatric conditions.
- Understanding the full spectrum of dexamethasone's side effects is crucial for patient safety.
Observation:
- Three pediatric patients receiving high-dose dexamethasone developed hepatomegaly (enlarged liver).
- These patients also exhibited disturbances in liver function tests.
- All observed liver abnormalities were reversible upon dexamethasone withdrawal.
Findings:
- High-dose dexamethasone administration is associated with reversible hepatomegaly and transient liver dysfunction in children.
- The study supports a direct correlation between dexamethasone dosage and the observed liver effects.
Implications:
- Clinicians should monitor liver function in pediatric patients undergoing high-dose dexamethasone therapy.
- Discontinuation of dexamethasone should be considered if hepatomegaly or liver function abnormalities arise.
- Further research may elucidate the precise mechanisms of dexamethasone-induced hepatotoxicity in children.